Investment Analysts’ Recent Ratings Changes for Ryan Specialty (RYAN)

Key Takeaways:

• Morgan Stanley lowered Ryan Specialty’s price target from $71.00 to $68.00
• Analysts at Morgan Stanley retained an “overweight” rating
• Cantor Fitzgerald upgraded Ryan Specialty on August 13, 2025
• Both changes occurred in August 2025
• The story was originally published on September 2, 2025

Introduction

Ryan Specialty (NYSE: RYAN) has recently found itself in the spotlight due to notable analyst updates within the span of a few days in August 2025. Multiple firms revised their long-term outlooks on the stock, prompting investors to pay attention to these latest assessments.

Morgan Stanley’s Revised Target

On August 18, 2025, Morgan Stanley lowered its price target for Ryan Specialty from $71.00 down to $68.00. Despite this reduction, the firm maintained its “overweight” rating on the stock, suggesting that it still sees potential upside. This update reflects a slightly more measured approach to Ryan Specialty’s valuation while staying bullish about the company’s broader prospects.

Cantor Fitzgerald’s Upgrade

Just days earlier, on August 13, 2025, Cantor Fitzgerald announced an upgrade for Ryan Specialty. Although fewer details were provided about Cantor Fitzgerald’s reasoning, the shift signaled renewed confidence from another influential analyst. Coupled with Morgan Stanley’s adjusted price target, this upgrade highlights the evolving market perspective on Ryan Specialty.

Conclusion

Overall, the mid-August updates from Morgan Stanley and Cantor Fitzgerald underscore the company’s ongoing importance to prominent analyst firms. While Morgan Stanley chose to take a slightly more conservative position by lowering its price target, its “overweight” stance remains intact. Meanwhile, Cantor Fitzgerald’s upgrade suggests a rising optimism about the company’s future. As of the story’s publication date—September 2, 2025—these analyst actions continue to shape the conversation around Ryan Specialty’s market performance.